Pular para o conteúdo
Porfiria eritropoiética
ORPHA:659681PCDT · SUSDOENÇA RARA
Esta doença tem causa genética. Recomendamos procurar um médico geneticista para diagnóstico, exames genéticos e aconselhamento familiar.
Sangue / imune
Também conhecida comoEPPEPP
Sinônimos clínicos: EPP

Distúrbio metabólico congênito raro caracterizado por um erro congênito da biossíntese de porfirina-heme. Os sinais e sintomas incluem fotossensibilidade cutânea dolorosa que leva a bolhas e cicatrizes nas áreas expostas da pele, eritrodontia, descoloração vermelha da urina, anemia hemolítica e esplenomegalia.

Em construçãohistóricoSugerir correção
Mantido por Agente Raras·Colaborar como especialista →

Introdução

O que você precisa saber de cara

💬
EM LINGUAGEM SIMPLES

A porfiria eritropoiética é uma condição genética rara em que o organismo apresenta uma alteração congênita na produção do heme, componente essencial das hemácias. Os sinais mais perceptíveis incluem sensibilidade extrema e dolorosa na pele à luz solar, que pode causar vermelhidão, bolhas e cicatrizes, além de dentes avermelhados e urina de cor escura ou avermelhada. O quadro também pode levar a problemas no sangue, como anemia, e a sobrecarga no fígado. No Brasil, o Ministério da Saúde conta com um protocolo para porfirias, porém este subtipo possui cobertura parcial e não há remédios específicos dispensados pelo SUS cadastrados na base oficial.

📋
Informacoes curadas por IA — podem conter imprecisoes

Distúrbio metabólico congênito raro caracterizado por um erro congênito da biossíntese de porfirina-heme. Os sinais e sintomas incluem fotossensibilidade cutânea dolorosa que leva a bolhas e cicatrizes nas áreas expostas da pele, eritrodontia, descoloração vermelha da urina, anemia hemolítica e esplenomegalia.

Pesquisas ativas
5 ensaios
30 total registrados no ClinicalTrials.gov
Publicações científicas
446 artigos
Último publicado: 2026 Mar 18
🏥
SUS: Cobertura parcialScore: 20%
PCDT disponívelCentros em: PA, PE, BA, RN, DF +8
Você se identifica com essa condição?
O Raras está aqui pra te apoiar — com ou sem diagnóstico

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Entender a doença

Do básico ao detalhe, leia no seu ritmo

Preparando trilha educativa...

Sinais e sintomas

O que aparece no corpo e com que frequência cada sintoma acontece

Partes do corpo afetadas

🫃
Digestivo
4 sintomas
🩸
Sangue
3 sintomas
🧬
Pele e cabelo
2 sintomas

+ 8 sintomas em outras categorias

Características mais comuns

—
Anemia microcítica
—
Cirrose
—
Eritema
—
Função hepática diminuída
—
Fotossensibilidade cutânea
—
Dermatite eczematoide
17sintomas
Sem dados (17)

Os sintomas variam de pessoa para pessoa. Abaixo estão as 17 características clínicas mais associadas, ordenadas por frequência.

Anemia microcíticaMicrocytic anemia
CirroseCirrhosis
EritemaErythema
Função hepática diminuídaDecreased liver function
Fotossensibilidade cutâneaCutaneous photosensitivity

Linha do tempo da pesquisa

Publicações por ano — veja quando o interesse científico cresceu
Anos de pesquisa1desde 2026
Total histórico446PubMed
Últimos 10 anos104publicações
Pico201914 papers
Linha do tempo
2026Hoje · 2026🧪 1996Primeiro ensaio clínico📈 2019Ano de pico
Publicações por ano (últimos 10 anos)

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Genética e causas

O que está alterado no DNA e como passa nas famílias

Genes associados

3 genes identificados com associação a esta condição.

FECHFerrochelatase, mitochondrialDisease-causing germline mutation(s) inTolerante
VIAS BIOLÓGICAS (2)
Heme biosynthesisMitochondrial protein degradation
MECANISMO DE DOENÇA

Protoporphyria, erythropoietic, 1

An autosomal recessive form of porphyria with onset usually before age 10 years. Porphyrias are inherited defects in the biosynthesis of heme, resulting in the accumulation and increased excretion of porphyrins or porphyrin precursors. They are classified as erythropoietic or hepatic, depending on whether the enzyme deficiency occurs in red blood cells or in the liver. Erythropoietic protoporphyria is marked by excessive protoporphyrin in erythrocytes, plasma, liver and feces, and by widely varying photosensitive skin changes ranging from a burning or pruritic sensation to erythema, edema and wheals.

EXPRESSÃO TECIDUAL(Ubíquo)
Fibroblastos
22.7 TPM
Rim - Medula
21.6 TPM
Glândula adrenal
18.7 TPM
Linfócitos
18.6 TPM
Músculo esquelético
18.3 TPM
OUTRAS DOENÇAS (2)
protoporphyria, erythropoietic, 1autosomal erythropoietic protoporphyria
HGNC:3647UniProt:P22830
ALAS25-aminolevulinate synthase, erythroid-specific, mitochondrialDisease-causing germline mutation(s) inAltamente restrito
VIAS BIOLÓGICAS (1)
Heme biosynthesis
MECANISMO DE DOENÇA

Anemia, sideroblastic, 1

A form of sideroblastic anemia that shows a variable hematologic response to pharmacologic doses of pyridoxine. Sideroblastic anemia is characterized by anemia of varying severity, hypochromic peripheral erythrocytes, systemic iron overload secondary to chronic ineffective erythropoiesis, and the presence of bone marrow ringed sideroblasts. Sideroblasts are characterized by iron-loaded mitochondria clustered around the nucleus.

VIAS REACTOME (1)
OUTRAS DOENÇAS (2)
X-linked erythropoietic protoporphyriaX-linked sideroblastic anemia 1
HGNC:397UniProt:P22557
CLPXATP-dependent clpX-like chaperone, mitochondrialDisease-causing germline mutation(s) inRestrito
VIAS BIOLÓGICAS (1)
Mitochondrial protein degradation
MECANISMO DE DOENÇA

Protoporphyria, erythropoietic, 2

An autosomal dominant form of porphyria with onset in infancy. Porphyrias are inherited defects in the biosynthesis of heme, resulting in the accumulation and increased excretion of porphyrins or porphyrin precursors. They are classified as erythropoietic or hepatic, depending on whether the enzyme deficiency occurs in red blood cells or in the liver. Erythropoietic protoporphyria is marked by excessive protoporphyrin in erythrocytes, plasma, liver and feces, and by widely varying photosensitive skin changes ranging from a burning or pruritic sensation to erythema, edema and wheals.

OUTRAS DOENÇAS (1)
protoporphyria, erythropoietic, 2
HGNC:HGNC:2088UniProt:O76031

Variantes genéticas (ClinVar)

389 variantes patogênicas registradas no ClinVar.

🧬 CLPX: NM_006660.5(CLPX):c.1841A>G (p.Glu614Gly) ()
🧬 CLPX: NM_006660.5(CLPX):c.1271A>G (p.Asn424Ser) ()
🧬 CLPX: Single allele ()
🧬 CLPX: Single allele ()
🧬 CLPX: NM_006660.5(CLPX):c.893G>A (p.Gly298Asp) ()
Ver todas no ClinVar

Vias biológicas (Reactome)

2 vias biológicas associadas aos genes desta condição.

Diagnóstico

Os sinais que médicos procuram e os exames que confirmam

Carregando...

Tratamento e manejo

Remédios, cuidados de apoio e o que precisa acompanhar

Pipeline de tratamentos
Pipeline regulatório — de medicamentos já aprovados a drogas em pesquisa exploratória.
3Fase 310
2Fase 27
1Fase 11
·Pré-clínico12
Medicamentos catalogadosEnsaios clínicos· 0 medicamentos · 30 ensaios
Carregando informações de tratamento...

Onde tratar no SUS

Hospitais de referência no Brasil e o protocolo oficial do SUS (PCDT)

🇧🇷 Atendimento SUS — Porfiria eritropoiética

Centros de Referência SUS

21 centros habilitados pelo SUS para Porfiria eritropoiética

Centros para Porfiria eritropoiética

Detalhes dos centros

Hospital Universitário Prof. Edgard Santos (HUPES)

R. Dr. Augusto Viana, s/n - Canela, Salvador - BA, 40110-060 · CNES 0003808

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do Metabolismo

Hospital de Apoio de Brasília (HAB)

AENW 3 Lote A Setor Noroeste - Plano Piloto, Brasília - DF, 70684-831 · CNES 0010456

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do MetabolismoDeficiência Intelectual

Hospital Estadual Infantil e Maternidade Alzir Bernardino Alves (HIABA)

Av. Min. Salgado Filho, 918 - Soteco, Vila Velha - ES, 29106-010 · CNES 6631207

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do MetabolismoDeficiência Intelectual

Hospital das Clínicas da UFG

Rua 235 QD. 68 Lote Área, Nº 285, s/nº - Setor Leste Universitário, Goiânia - GO, 74605-050 · CNES 2338424

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do Metabolismo

Hospital das Clínicas da UFMG

Av. Prof. Alfredo Balena, 110 - Santa Efigênia, Belo Horizonte - MG, 30130-100 · CNES 2280167

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do MetabolismoDeficiência Intelectual

NUPAD / Faculdade de Medicina UFMG

Av. Prof. Alfredo Balena, 189 - 5 andar - Centro, Belo Horizonte - MG, 30130-100 · CNES 2183226

Serviço de Referência

Rota
Erros Inatos do Metabolismo

Hospital Universitário João de Barros Barreto

R. dos Mundurucus, 4487 - Guamá, Belém - PA, 66073-000 · CNES 2337878

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do MetabolismoDeficiência Intelectual

Hospital de Clínicas da Universidade Federal de Pernambuco

Av. Prof. Moraes Rego, 1235 - Cidade Universitária, Recife - PE, 50670-901 · CNES 2561492

Atenção Especializada

Rota
Erros Inatos do Metabolismo

Instituto de Medicina Integral Prof. Fernando Figueira (IMIP)

R. dos Coelhos, 300 - Boa Vista, Recife - PE, 50070-902 · CNES 0000647

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do MetabolismoDeficiência Intelectual

Hospital de Clínicas da UFPR

R. Gen. Carneiro, 181 - Alto da Glória, Curitiba - PR, 80060-900 · CNES 2364980

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do MetabolismoDeficiência Intelectual

Hospital Universitário Pedro Ernesto (HUPE-UERJ)

Blvd. 28 de Setembro, 77 - Vila Isabel, Rio de Janeiro - RJ, 20551-030 · CNES 2280221

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do Metabolismo

Instituto Nacional de Saúde da Mulher, da Criança e do Adolescente Fernandes Figueira (IFF/Fiocruz)

Av. Rui Barbosa, 716 - Flamengo, Rio de Janeiro - RJ, 22250-020 · CNES 2269988

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do MetabolismoDeficiência Intelectual

Hospital Universitário Onofre Lopes (HUOL)

Av. Nilo Peçanha, 620 - Petrópolis, Natal - RN, 59012-300 · CNES 2408570

Atenção Especializada

Rota
Erros Inatos do Metabolismo

Hospital São Lucas da PUCRS

Av. Ipiranga, 6690 - Jardim Botânico, Porto Alegre - RS, 90610-000 · CNES 2232928

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do Metabolismo

Hospital de Clínicas de Porto Alegre (HCPA)

Rua Ramiro Barcelos, 2350 Bloco A - Av. Protásio Alves, 211 - Bloco B e C - Santa Cecília, Porto Alegre - RS, 90035-903 · CNES 2237601

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do MetabolismoDeficiência Intelectual

Hospital Universitário da UFSC (HU-UFSC)

R. Profa. Maria Flora Pausewang - Trindade, Florianópolis - SC, 88036-800 · CNES 2560356

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do Metabolismo

Hospital das Clínicas da FMUSP

R. Dr. Ovídio Pires de Campos, 225 - Cerqueira César, São Paulo - SP, 05403-010 · CNES 2077485

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do MetabolismoDeficiência Intelectual

Hospital de Clínicas da UNICAMP

R. Vital Brasil, 251 - Cidade Universitária, Campinas - SP, 13083-888 · CNES 2748223

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do MetabolismoDeficiência Intelectual

Hospital de Clínicas de Ribeirão Preto (HCRP-USP)

R. Ten. Catão Roxo, 3900 - Vila Monte Alegre, Ribeirão Preto - SP, 14015-010 · CNES 2082187

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do MetabolismoDeficiência Intelectual

Instituto da Criança e do Adolescente (ICr-HCFMUSP)

Av. Dr. Enéas Carvalho de Aguiar, 647 - Cerqueira César, São Paulo - SP, 05403-000 · CNES 2081695

Serviço de Referência

Rota
Erros Inatos do Metabolismo

UNIFESP / Hospital São Paulo

R. Napoleão de Barros, 715 - Vila Clementino, São Paulo - SP, 04024-002 · CNES 2688689

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do Metabolismo
Sobre os centros SUS: Estes centros são habilitados pelo Ministério da Saúde como Serviços de Referência em Doenças Raras ou Serviços de Atenção Especializada. O atendimento é pelo SUS, com encaminhamento da rede de atenção básica.

Dados de DATASUS/CNES, SBGM, ABNeuro e Ministério da Saúde. Sempre confirme a disponibilidade diretamente com o estabelecimento.

Pesquisa ativa

Ensaios clínicos abertos e novidades científicas recentes

Onde estão os ensaios

Com ensaio aberto em 10 países. O ponto verde marca onde há vaga agora.

🟢 Recrutando agora

5 pesquisas recrutando participantes. Converse com seu médico sobre a possibilidade de participar.

Outros ensaios clínicos

30 ensaios clínicos encontrados, 5 ativos.

Distribuição por fase
NCT06971900 · GATEWAY: A Phase 2a Study of PORT-77 in Adults With Erythrop…Concluído
PHASE2🇺🇸 Estados Unidos
NCT06910358 · Study of Bitopertin in Participants With EPP or XLP (APOLLO)Concluído
PHASE3🇦🇺 Austrália · 🇧🇪 Bélgica · 🇨🇦 Canadá +9
NCT06388642 · Pharmacokinetics of Afamelanotide in Erythropoietic Protopor…Concluído
PHASE1, PHASE2🇧🇪 Bélgica · 🇳🇱 Países Baixos
NCT06144840 · INcreased Sun Exposure Without Pain In Research Participants…Concluído
PHASE3🇦🇺 Austrália · Bulgaria · 🇨🇿 Tchéquia +8
NCT05308472 · Study of Bitopertin to Evaluate the Safety, Tolerability, Ef…Concluído
PHASE2🇺🇸 Estados Unidos
NCT05572125 · Iron Therapy in Erythropoietic ProtoporphyriaConcluído
🇩🇰 Dinamarca
NCT05020184 · Effect of Oral Cimetidine in the ProtoporphyriasConcluído
PHASE2🇺🇸 Estados Unidos
NCT03520036 · Study to Evaluate Efficacy, Safety, and Tolerability of MT-7…Concluído
PHASE2🇺🇸 Estados Unidos
NCT03682731 · Light Exposure Patterns and Symptoms Among Patients With Ery…Concluído
🇩🇰 Dinamarca
NCT02979249 · Oral Iron for Erythropoietic ProtoporphyriasConcluído
NA🇺🇸 Estados Unidos
NCT01688895 · Erythropoietic Protoporphyrias: Studies of the Natural Histo…Concluído
🇺🇸 Estados Unidos
NCT01605136 · Phase III Confirmatory Study in Erythropoietic Protoporphyri…Concluído
PHASE3🇺🇸 Estados Unidos
NCT01880983 · Mitoferrin-1 Expression in Erythropoietic Protoporphyria (Po…Concluído
🇺🇸 Estados Unidos
NCT04578496 · A Safety Extension Study in Patients With Erythropoietic Pro…Concluído
PHASE3
NCT01422915 · Sorbent Therapy of the Cutaneous PorphyriasConcluído
PHASE2, PHASE3🇺🇸 Estados Unidos
NCT01097044 · Phase II Confirmatory Study in Erythropoietic Protoporphyria…Concluído
PHASE2🇺🇸 Estados Unidos
NCT00979745 · Phase III Confirmatory Study in Erythropoietic Protoporphyri…Concluído
PHASE3🇫🇮 Finlândia · 🇫🇷 França · 🇩🇪 Alemanha +3
NCT04053270 · Multicentre Phase III Erythropoietic Protoporphyria StudyConcluído
PHASE3
NCT00004831 · Study of Cysteine Hydrochloride for Erythropoietic Protoporp…Concluído
NA
NCT00004940 · Phase III Study of L-Cysteine in Patients With Erythropoieti…Concluído
PHASE3
NCT05780840 · Protection Against Visible Light by Dihydroxyacetone in Eryt…UNKNOWN
NA🇩🇰 Dinamarca
NCT00206869 · Does Exercise and Heat Increase the Lightsensibility in Pati…UNKNOWN
NA🇩🇰 Dinamarca
NCT01550705 · Effect of Isoniazid on Protoporphyrin Levels in Erythropoiet…Encerrado
NA🇺🇸 Estados Unidos
NCT07123363 · Effect of Bitopertin on the Liver and on Levels of Protoporp…Cancelado
PHASE1
NCT07603401 · Expanded Access Program of Bitopertin For Participants With …AVAILABLE
🇺🇸 Estados Unidos
Ver todos no ClinicalTrials.gov
🧪 Está conduzindo uma pesquisa?
Divulgue para pacientes e familiares que acompanham esta doença.
Divulgar pesquisa →

Publicações mais relevantes

Timeline de publicações
102 papers (10 anos)
#1

Hematopoietic stem cell transplantation for erythropoietic porphyria-induced acute liver failure: a case report and literature review.

Clinics and research in hepatology and gastroenterology2026 Mar 10

Protoporphyrias are rare genetic disorders in heme biosynthesis, causing protoporphyrin IX accumulation with progressive liver injury. Liver transplantation has traditionally treated protoporphyria-induced liver injury but does not correct the underlying hematopoietic defect. We present a 16-year-old male with painful cutaneous photosensitivity who developed cholestatic liver dysfunction and severe abdominal pain. After plasmapheresis, red blood cell (RBC) transfusions, and intravenous hemin, he had transient improvement and subsequently underwent hematopoietic stem cell transplantation (HSCT) without liver transplantation, which normalized his protoporphyrin levels, liver function, and symptoms. This case underscores HSCT as a disease-modifying therapy that may prevent liver transplantation when performed before irreversible hepatic damage.

#2

Congenital Erythropoietic Porphyria with Persistent Severe Biochemical Abnormalities and a Non-Mutilating Clinical Course: A Case Report.

Reports (MDPI)2026 Feb 16

Background and Clinical Significance: Congenital erythropoietic porphyria (CEP), also known as Günther disease, is a rare autosomal recessive porphyria caused by a deficiency of uroporphyrinogen III synthase, leading to the accumulation of phototoxic type I porphyrins. CEP classically presents in infancy with severe photosensitivity, blistering, scarring, and hemolytic anemia; however, significant phenotypic variability has increasingly been recognized. Case Presentation: We report a 32-year-old woman diagnosed with CEP in early infancy who demonstrated persistently and profoundly elevated erythrocyte porphyrin levels over more than a decade, yet who followed a relatively non-mutilating clinical course. Genetic testing identified a low-penetrance intronic UROS variant typically associated with erythropoietic protoporphyria, underscoring diagnostic challenges and genotype-phenotype discordance. The patient experienced marked improvement in photosensitivity and burning pain after initiation of afamelanotide, without the need for transfusion therapy or stem cell transplantation. Conclusions: This case highlights the heterogeneity of CEP, the importance of long-term biochemical follow up, and the potential role of afamelanotide in improving quality of life for selected patients with CEP.

#3

Congenital Erythropoietic Porphyria in a Neonate: Utility of Rapid Whole Genome Sequencing - A Case Report.

Neonatology2026

Congenital erythropoietic porphyria (CEP), especially neonatal-onset CEP, is a rare autosomal recessive disorder with an estimated incidence of one in one million. It is caused by UROS gene variants and may mimic severe systemic conditions, delaying diagnosis. We report a male neonate born with asphyxia, hepatosplenomegaly, cytopenia, and multiorgan dysfunction, initially suspected to have familial hemophagocytic lymphohistiocytosis. Targeted panels for familial hemophagocytic lymphohistiocytosis and autoinflammatory disorders were negative. Red urine and photosensitive blistering lesions were observed. Rapid trio whole genome sequencing identified a homozygous NM_000375.3 (UROS):c.562G>T (p.Gly188Trp) variant previously reported only in compound heterozygous patients and classified as pathogenic in ClinVar (RCV000003959). Subsequent biochemical testing confirmed markedly elevated porphyrin levels, establishing a diagnosis of CEP. This case highlights the diagnostic challenges of neonatal CEP, where systemic illness may obscure the classical signs. This underscores the value of a genomics-first approach in critically ill neonates.

#4

Hematopoietic stem cell transplantation in pediatric congenital erythropoietic porphyria: a French retrospective multicenter registry study on behalf of the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC).

Bone marrow transplantation2026 Mar 18
#5

Porphyrias: Pathophysiology and clinical management recommendations for hepatologists.

Hepatology communications2025 Dec 01

In humans, an enzyme dysfunction in heme biosynthesis results in a heterogenous group of diseases collectively known as porphyrias. From a clinical standpoint, porphyrias can be classified as erythropoietic (congenital erythropoietic porphyria-CEP, erythropoietic/X-linked protoporphyria-EPP/XLP) or hepatic (acute hepatic porphyrias-AHPs, porphyria cutanea tarda-PCT), according to the site of organ dysfunction deemed to be responsible for the disease. In terms of total heme production, the liver accounts for the second major heme-synthesizing organ, after the bone marrow. In fact, heme is necessary as a prosthetic group in countless biologic functions, to which hepatic contribution is essential. Furthermore, the pathway of heme biosynthesis is inscribed into a network of fundamental metabolic reactions largely occurring in hepatocytes. Independent of their classification, all porphyrias share some degree of involvement of the liver, either in the pathogenesis, clinical manifestations, or as a preferential target of damage. Crucially, even those types of porphyrias that have been classically defined as erythropoietic do present a hepatic involvement, which can lead to poor clinical outcomes if neglected. Therefore, hepatologists should consider porphyrias as a differential diagnosis for otherwise unexplained presentations of liver disease. At the same time, a multidisciplinary team dealing with the diagnostic workup and clinical management of all types of porphyrias must include an expert in liver diseases. In this review, we aimed to recapitulate the main aspects of liver involvement in porphyrias, while also providing practical tools to recognize and manage these conditions from the hepatologist's perspective.

Publicações recentes

Ver todas no PubMed

📚 EuropePMC320 artigos no totalmostrando 102

2026

Hematopoietic stem cell transplantation in pediatric congenital erythropoietic porphyria: a French retrospective multicenter registry study on behalf of the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC).

Bone marrow transplantation
2026

Hematopoietic stem cell transplantation for erythropoietic porphyria-induced acute liver failure: a case report and literature review.

Clinics and research in hepatology and gastroenterology
2026

Congenital Erythropoietic Porphyria with Persistent Severe Biochemical Abnormalities and a Non-Mutilating Clinical Course: A Case Report.

Reports (MDPI)
2026

Congenital Erythropoietic Porphyria in a Neonate: Utility of Rapid Whole Genome Sequencing - A Case Report.

Neonatology
2025

Porphyrias: Pathophysiology and clinical management recommendations for hepatologists.

Hepatology communications
2025

[Two siblings with congenital erythropoietic porphyria in one family: case report and literature review].

Zhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics
2025

Late recurrence of congenital erythropoietic porphyria symptoms after initial remission post-bone marrow transplant.

Indian journal of dermatology, venereology and leprology
2025

Congenital Erythropoietic Porphyria.

JAMA dermatology
2025

Identification of a novel nonsense mutation and a recurrent missense mutation in UROS gene in a patient with congenital erythropoietic porphyria.

Frontiers in genetics
2025

Congenital erythropoietic porphyria: the overlooked inherited disorder.

BMJ case reports
2025

Scavenger endothelial cells alleviate tissue damage by engulfing toxic molecules derived from hemolysis.

Proceedings of the National Academy of Sciences of the United States of America
2025

Needle-like red cell inclusions in congenital erythropoietic porphyria.

British journal of haematology
2024

Severe Acute Porphyria Exacerbation Post Intravenous Iron Infusion: A Case Report.

Cureus
2025

Congenital Erythropoietic Porphyria: A Case of Hepatic Failure and Angioedema Following Ferrous Sulfate Supplementation.

Pediatric dermatology
2024

Afamelanotide in protoporphyria and other skin diseases: a review.

Postepy dermatologii i alergologii
2024

From chemistry to genomics: A concise history of the porphyrias.

Liver international : official journal of the International Association for the Study of the Liver
2024

The role of allogeneic stem cell transplantation in severe erythropoietic protoporphyria in adults and young adults: timing and modalities.

Hematology, transfusion and cell therapy
2024

Porto-Sinusoidal Vascular Disease in Congenital Erythropoietic Porphyria Needing Liver Transplantation.

ACG case reports journal
2024

Successful treatment of congenital erythropoietic porphyria using matched unrelated hematopoietic stem cell transplantation in an adult: A case report.

Skin health and disease
2024

Congenital Erythropoietic Porphyria: A Rare Inherited Disorder.

Cureus
2024

Causal effect of porphyria biomarkers on alcohol-related hepatocellular carcinoma through Mendelian Randomization.

PloS one
2024

Congenital erythropoietic porphyria five years observation with standard treatment: a case report.

Oxford medical case reports
2024

Severe Perinatal Presentations of Günther's Disease: Series of 20 Cases and Perspectives.

Life (Basel, Switzerland)
2023

Congenital erythropoietic porphyria presenting with recurrent epistaxis: a case report.

Journal of medical case reports
2024

Clonal hematopoiesis and acquired genetic abnormalities of the red cell: An historical review.

Blood cells, molecules & diseases
2023

Acute Porphyria: An Unusual Case Of Quadriparesis, Hypertension, Recurrent Severe Cyclic Abdominal Pain, And Seizures.

JPMA. The Journal of the Pakistan Medical Association
2024

Update on the Porphyrias.

Annual review of medicine
2023

Twelve-year follow-up of bone marrow transplantation in congenital erythropoietic porphyria: lessons learned from a challenging case.

Clinical and experimental dermatology
2023

Ocular protection in congenital erythropoietic porphyria: A potential role for gaming glasses.

Photodermatology, photoimmunology & photomedicine
2023

Bullous lesions following phototherapy in a newborn.

Einstein (Sao Paulo, Brazil)
2023

Porphyrias: Uncommon disorders masquerading as common childhood diseases.

Journal of postgraduate medicine
2024

Lagophthalmos-induced corneal perforation in a patient with congenital erythropoietic porphyria.

Orbit (Amsterdam, Netherlands)
2023

Acquired erythropoietic uroporphyria associated with clonal cytopenia of undetermined significance.

JAAD case reports
2023

Very Early Diagnosis and Management of Congenital Erythropoietic Porphyria.

Clinical pediatrics
2022

Role of phlebotomy in the treatment of liver damage related to erythropoietic porphyria.

Scientific reports
2022

Novel mutation in the UROS gene causing congenital erythropoietic porphyria in an elderly Japanese female.

The Journal of dermatology
2022

Late-Onset Congenital Erythropoietic Porphyria.

JAMA dermatology
2021

Iron, Heme Synthesis and Erythropoietic Porphyrias: A Complex Interplay.

Metabolites
2021

An Atypical Case of Congenital Erythropoietic Porphyria.

Genes
2022

Cardiopulmonary bypass in a child with erythropoietic protoporphyria.

The Australasian journal of dermatology
2022

Acquired erythropoietic uroporphyria secondary to myeloid malignancy: A case report and literature review.

Photodermatology, photoimmunology & photomedicine
2021

Hematopoietic stem cell transplant for erythropoietic porphyrias in pediatric patients.

Pediatric blood & cancer
2023

Perinatal onset of severe congenital erythropoietic porphyria.

Archives of disease in childhood. Fetal and neonatal edition
2021

Bone marrow erythroid cell inclusions reveal congenital erythropoietic porphyria.

British journal of haematology
2021

Improving the Pharmacological Properties of Ciclopirox for Its Use in Congenital Erythropoietic Porphyria.

Journal of personalized medicine
2021

Hypertrichosis and erythrodontia in congenital erythropoietic porphyria.

EJHaem
2021

Acitretin mitigates uroporphyrin-induced bone defects in congenital erythropoietic porphyria models.

Scientific reports
2021

Congenital erythropoietic porphyria: A case series of a rare uroporphyrinogen III synthase gene mutation in Nepalese patients.

JAAD case reports
2021

Case Report: A Possible Case of Congenital Erythropoietic Porphyria in a Gir Calf: A Clinical, Pathological, and Molecular Approach.

Frontiers in veterinary science
2021

Identification of novel UROS mutations in a patient with congenital erythropoietic porphyria and efficient treatment by phlebotomy.

Molecular genetics and metabolism reports
2021

Metabolic Landscape of the Mouse Liver by Quantitative 31 P Nuclear Magnetic Resonance Analysis of the Phosphorome.

Hepatology (Baltimore, Md.)
2020

A simple Rx for congenital erythropoietic porphyria.

Blood
2021

Use of polarized dermoscopy in the evaluation of congenital erythropoietic porphyria.

Clinical and experimental dermatology
2020

Mutation-Specific Guide RNA for Compound Heterozygous Porphyria On-target Scarless Correction by CRISPR/Cas9 in Stem Cells.

Stem cell reports
2020

Congenital erythropoietic porphyria (Gunther disease): a case report.

Oxford medical case reports
2020

Iron chelation rescues hemolytic anemia and skin photosensitivity in congenital erythropoietic porphyria.

Blood
2020

Mild iron deficiency does not ameliorate the phenotype of a murine erythropoietic protoporphyria model.

American journal of hematology
2021

Phlebotomy as an efficient long-term treatment of congenital erythropoietic porphyria.

Haematologica
2020

Bone Marrow Transplantation in Congenital Erythropoietic Porphyria: Sustained Efficacy but Unexpected Liver Dysfunction.

Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation
2020

Phototherapy in the Evaluation and Management of Photodermatoses.

Dermatologic clinics
2019

Genetic background influences hepcidin response to iron imbalance in a mouse model of hemolytic anemia (Congenital erythropoietic porphyria).

Biochemical and biophysical research communications
2019

Ocular manifestations in patient with congenital erythropoietic porphyria.

Indian journal of ophthalmology
2019

Heme biosynthesis and the porphyrias.

Molecular genetics and metabolism
2019

Congenital Erythropoietic Porphyria: A Rare Case of Photosensitivity with Hemolytic Anaemia and Mental Retardation.

Journal of the College of Physicians and Surgeons--Pakistan : JCPSP
2019

Clinical Guide and Update on Porphyrias.

Gastroenterology
2019

CRISPR-Cas9 genome editing induces megabase-scale chromosomal truncations.

Nature communications
2019

Murine models of the human porphyrias: Contributions toward understanding disease pathogenesis and the development of new therapies.

Molecular genetics and metabolism
2019

[The cutaneous porphyrias].

Annales de dermatologie et de venereologie
2019

Congenital erythropoietic porphyria with erythrodontia: A case report.

International journal of paediatric dentistry
2019

Congenital erythropoietic porphyria: Recent advances.

Molecular genetics and metabolism
2019

Molecular expression, characterization and mechanism of ALAS2 gain-of-function mutants.

Molecular medicine (Cambridge, Mass.)
2019

Recent advances on porphyria genetics: Inheritance, penetrance & molecular heterogeneity, including new modifying/causative genes.

Molecular genetics and metabolism
2019

Congenital erythropoietic porphyria and erythropoietic protoporphyria: Identification of 7 uroporphyrinogen III synthase and 20 ferrochelatase novel mutations.

Molecular genetics and metabolism
2019

Anaesthetic concerns in the patients with congenital erythropoietic porphyria for ocular surgery.

Journal of clinical anesthesia
2018

Scleritis in congenital erythropoietic porphyria - infective or inflammatory?

Indian journal of ophthalmology
2018

Repurposing ciclopirox as a pharmacological chaperone in a model of congenital erythropoietic porphyria.

Science translational medicine
2018

Acquired erythropoietic uroporphyria and myelodysplastic syndrome cured by bone marrow transplantation.

The British journal of dermatology
2018

Brain perfusion defects by SPET/CT and neurostat semi-quantitative analysis in two patients with congenital erythropoietic porphyria.

Hellenic journal of nuclear medicine
2018

[Congenital erythropoietic porphyria: case report and management recommendations].

Archivos argentinos de pediatria
2018

Prevention of photosensitivity with action spectrum adjusted protection for erythropoietic protoporphyria.

The Journal of dermatology
2017

Neonatal hemolytic anemia does not always indicate thalassemia: a case report.

BMC research notes
2018

Acquired erythropoietic uroporphyria secondary to myelodysplastic syndrome with chromosome 3 alterations: a case report.

The British journal of dermatology
2017

Neonatal-Onset Hereditary Coproporphyria: A New Variant of Hereditary Coproporphyria.

JIMD reports
2017

Missense UROS mutations causing congenital erythropoietic porphyria reduce UROS homeostasis that can be rescued by proteasome inhibition.

Human molecular genetics
2017

Congenital erythropoietic porphyria (Gunther disease) - long-term follow up of a case and review.

Dermatology online journal
2017

Hemolytic anemia repressed hepcidin level without hepatocyte iron overload: lesson from Günther disease model.

Haematologica
2016

Congenital erythropoietic porphyria: mild presentation with late onset associated with a mutation in the UROS gene promoter sequence.

Clinical and experimental dermatology
2016

A Case of Congenital Erythropoietic Porphyria without Haemolysis.

European journal of case reports in internal medicine
2016

Congenital Erythropoietic Porphyria with Undescended Testis.

Indian journal of dermatology
2016

Cutaneous Porphyrias: Causes, Symptoms, Treatments and the Danish Incidence 1989-2013.

Acta dermato-venereologica
2016

Late-onset cutaneous porphyria in a patient heterozygous for a uroporphyrinogen III synthase gene mutation.

The British journal of dermatology
2016

Advances in understanding the pathogenesis of congenital erythropoietic porphyria.

British journal of haematology
2016

A Rare Case of Puberty Onset Congenital Erythropoietic Porphyria with Ophthalmological Manifestations.

Middle East African journal of ophthalmology
2015

Scleral necrosis in congenital erythropoietic porphyria: A case report and review of the literature.

Oman journal of ophthalmology
2015

A Novel Mutation in the FECH Gene in a Czech Family with Erythropoietic Protoporphyria and a Population Study of IVS3-48C Variant Contributing to the Disease.

Folia biologica
2016

[Congenital erythropoietic porphyria : An update].

Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete
2015

Biology of Heme in Mammalian Erythroid Cells and Related Disorders.

BioMed research international
2015

Congenital Erythropoietic Porphyria With Calcific Constrictive Pericarditis: A Case Report and Brief Review of Literature.

World journal for pediatric & congenital heart surgery
2015

Successful hematopoietic stem cell transplantation in a child with congenital erythropoietic porphyria due to a mutation in GATA-1.

Pediatric transplantation
2015

Porphyria Diagnostics-Part 1: A Brief Overview of the Porphyrias.

Current protocols in human genetics
2015

Inducing iron deficiency improves erythropoiesis and photosensitivity in congenital erythropoietic porphyria.

Blood
2016

X-chromosomal inactivation directly influences the phenotypic manifestation of X-linked protoporphyria.

Clinical genetics
Ver todos os 320 no EuropePMC

Associações

Organizações que acompanham esta doença — pra ter apoio e orientação

Ainda não temos associações cadastradas para Porfiria eritropoiética.

É de uma associação que acompanha esta doença? Fale com a gente →

Doença com base genética

Um médico geneticista pode ajudar no diagnóstico de Porfiria eritropoiética e no aconselhamento genético da família.

Vai consultar um especialista? Confirme o registro dele no conselho.
Conselhos e sociedades

Doenças relacionadas

Doenças com sintomas parecidos — ajudam quem ainda está buscando diagnóstico

Perguntas frequentes

O que as famílias mais perguntam sobre esta doença — cada resposta com a fonte de onde saiu

Protocolo oficial relacionado (Ministério da Saúde)PCDT: Porfirias

Existe um documento oficial para "Porfirias". Ele pode não cobrir esta forma específica da doença — confira no texto do protocolo antes de contar com ele.

Respostas geradas por IA a partir das fontes citadas

A condição é causada por um erro inato da via de síntese de porfirina-heme, associando-se a mutações nos genes FECH, ALAS2 e CLPX. Esse defeito provoca a diminuição da atividade da enzima ferroquelatase e o acúmulo anormal de porfirinas no sangue e tecidos.

Referências

Fontes citadas no texto, publicações do grafo e bases de dados usadas neste verbete

5 publicações do grafo RarasNet (PubMed) · 6 bases de dados. Títulos, periódicos e PMIDs vêm direto da fonte, sem intermediação de IA.

  1. ORPHA:659681
    Orphanet
  2. Porfirias
    PCDT · Ministério da Saúde

Dados compilados pelo RarasNet a partir de fontes abertas (Orphanet, OMIM, MONDO, PubMed/EuropePMC, ClinicalTrials.gov, DATASUS, PCDT/MS). Este conteúdo é informativo e não substitui avaliação médica.

Citar este verbete

Raras. (s.d.). Porfiria eritropoiética. Em Raras — Enciclopédia de Doenças Raras do Brasil. https://raras.org/doenca/porfiria-eritropoietica

Formato APA. Conteúdo sob CC BY 4.0 — reuso livre com atribuição.

Conteúdo mantido por Agente Raras · Médicos e pesquisadores podem colaborar

Compêndio · Raras BR

Porfiria eritropoiética

ORPHA:659681 · MONDO:0001676
🇧🇷 Brasil SUS
Geral
Ensaios
5 ativos
MedGen
UMLS
C0162530
EuropePMC
Wikipedia
Papers 10a

📋 Origem dos dados

Esta página agrega dados de fontes públicas e oficiais. Dados sobre cobertura no SUS (PCDT, CEAF) são verificados ativamente por agente proativo (ver badge no infobox). Demais dados têm atribuição de fonte + data da última sincronização — clique para abrir o original.

Doença rara (ontologia)
fonte: Orphanet
Identificador unificado
fonte: MONDO
Indexação biomédica
fonte: MeSH (NLM)
Rara